Vaxenta Biotechnologies presented at the Leonhardt Ventures Technology Showcase on January 15th in San Francisco, CA. The company provided an update on IND enabling studies in melanoma and colon cancer animal models, as well as disclosed new data on safety studies.
Help employers find you! Check out all the jobs and post your resume.
